SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-17-019828
Filing Date
2017-03-29
Accepted
2017-03-29 07:03:56
Documents
1
Effectiveness Date
2017-03-29

Document Format Files

Seq Description Document Type Size
1 DEFA14A a17-2335_15defa14a.htm DEFA14A 27127
  Complete submission text file 0001104659-17-019828.txt   28334
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-30319 | Film No.: 17720642
SIC: 2834 Pharmaceutical Preparations